However, overexpression of HLA-G is frequently detected in patients with cancers and thus is viewed as a commonly immunosuppressive strategy employed by tumor to counteract effective immune responses by manipulating the phenotype and function of immune cells, such as DCs, macrophages, and NK and T cells (Table 2). Here, HLA-G is linked to cancer.